–
Статьи в журналах
-
- 2023 Real-world clinical effectiveness of Tixagevimab/Cilgavimab and Regdanvimab monoclonal antibodies for COVID-19 treatment in Omicron variant-dominant period
- Fomina Daria S., Lebedkina Marina S., Iliukhina Anna A., Kovyrshina Anna V., Shelkov Artem Y., Andreev Sergey S., Chernov Anton A., Dolzhikova Inna V., Kruglova Tatyana S., Andrenova Gerelma V., Tukhvatulin Amir I., Shcheblyakov Dmitry V., Karaulov Alexander V., Lysenko Maryana A., Logunov Denis Y., Gintsburg Alexander L.
- в журнале Frontiers in immunology, издательство Frontiers Research Foundation] ([Lausanne, Switzerland), том 14 DOI